Omega Healthcare Investors Inc expected to post earnings of 35 cents a share - Earnings Preview

Omega Healthcare Investors,

05/02/2024 21:24

* Omega Healthcare Investors Inc  OHI.N   OHI  is expected
to show
a rise in quarterly revenue when it reports  results on February
7 for the period ending December 31 2023
    * The Hunt Valley Maryland-based  company is expected to
report a
61.4% increase in revenue to $233.823 million from $144.85
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Omega Healthcare
Investors Inc
is for earnings of 35 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 12
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Omega
Healthcare
Investors Inc is $32.00​, above​ its last closing price
of $28.20. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.70        0.70       0.71      Beat    1.3
 Jun. 30 2023  0.69        0.68       0.74      Beat    8.3
 Mar. 31 2023  0.60        0.60       0.66      Beat    9.1​
 Dec. 31 2022              0.71                         
 ​​Sep.        0.75        0.74       0.76      Beat    2.5
 30 2022                                                
 Jun. 30 2022  0.73        0.73       0.76      Beat    4.1​
 Mar. 31 2022  0.69        0.70       0.74      Beat    6.4
 Dec. 31 2021  0.82        0.81       0.77      Missed  -5.3
 This summary was machine generated February 5 at 21:24 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)